Alnylam Pharmaceuticals
ALNY
#585
Rank
S$45.16 B
Marketcap
$351.78
Share price
1.81%
Change (1 day)
39.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: S$45.16 Billion

As of September 2024 Alnylam Pharmaceuticals has a market cap of S$45.16 Billion. This makes Alnylam Pharmaceuticals the world's 585th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024S$45.16 B42.36%
2023S$31.72 B-19.06%
2022S$39.19 B43.3%
2021S$27.35 B37.02%
2020S$19.96 B14.9%
2019S$17.37 B72.9%
2018S$10.04 B-40.37%
2017S$16.85 B262.41%
2016S$4.64 B-59%
2015S$11.34 B14.62%
2014S$9.89 B90.51%
2013S$5.19 B343.06%
2012S$1.17 B159.94%
2011S$0.45 B-16.18%
2010S$0.53 B-48.06%
2009S$1.03 B-29.66%
2008S$1.47 B-14.09%
2007S$1.71 B41.01%
2006S$1.21 B183.44%
2005S$0.42 B101.95%
2004S$0.21 B

End of Day market cap according to different sources

On Sep 15th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

S$44.35 Billion
by Yahoo Finance info icon info icon
S$44.35 Billion
by CompaniesMarketCap info icon info icon
S$44.35 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
S$3.33 B-92.61%๐Ÿ‡บ๐Ÿ‡ธ USA
S$165.89 B 267.34%๐Ÿ‡บ๐Ÿ‡ธ USA
S$15.48 B-65.71%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.48 B-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.13 B-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
S$307.69 B 581.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$187.17 B 314.46%๐Ÿ‡ซ๐Ÿ‡ท France
S$26.79 B-40.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel